Video

Presbyopia Awareness Month: Importance, treatment options

Author(s):

Sheryl Stevenson

April is Presbyopia Awareness Month. Brieann K. Adair, OD, of NYU Langone Health, speaks with Ophthalmology Times’ Sheryl Stevenson about the importance of Presbyopia awareness, treatment options and more.

Related Videos
Related Content
EyePoint Pharmaceuticals announces first patient dosed in global Phase 3 LUGANO clinical trial of Duravyu for wet AMD
October 24th 2024

EyePoint Pharmaceuticals announces first patient dosed in global Phase 3 LUGANO clinical trial of Duravyu for wet AMD

Ehsan Sadri, MD, and Colin Green, PhD: How a noninvasive eye drop therapy could transform keratoconus care
September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

Life Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual function
October 22nd 2024

Life Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual function

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Clearside Biomedical unveils positive topline results from ODYSSEY Phase 2b Trial of suprachoroidal CLS-AX in wet AMD
October 9th 2024

Clearside Biomedical unveils positive topline results from ODYSSEY Phase 2b Trial of suprachoroidal CLS-AX in wet AMD

Orasis Pharmaceuticals completes $78 million financing to support commercial launch of Qlosi
October 8th 2024

Orasis Pharmaceuticals completes $78 million financing to support commercial launch of Qlosi

© 2024 MJH Life Sciences

All rights reserved.